Multiple Sclerosis (MS) - Relapsing-remitting
32
11
13
10
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
3.1%
1 terminated out of 32 trials
90.9%
+4.4% vs benchmark
3%
1 trials in Phase 3/4
0%
0 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (32)
Effect of Low Histamine-Based Modified Mediterranean Diet in Multiple Sclerosis
Exploration of Novel Imaging Biomarkers on OCT for Ublituximab Treatment Response in Multiple Sclerosis
Educational Programs Based on Healthy Habits to Improve Quality of Life and Psychosocial Profile in Women With Neurodegenerative Diseases: The ADVICE Protocol Study (Phase 1)
Study to Investigate Vagus Nerve Stimulation Paired With Motor Task for Remyelination and Functional Recovery
Transcranial Direct Current Stimulation for Fatigue, Mood, and Cognition in Multiple Sclerosis
RESET-MS: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Multiple Sclerosis
Monthly Monitoring of Plasma NfL in Treated Relapsing-remitting Multiple Sclerosis to Detect Persistent Infraclinical Disease Activity
Effects of Low-Load Blood Flow Restriction Exercise on Rectus Femoris Muscle Morphology in Individuals With Relapsing-Remitting Multiple Sclerosis
Acute Intermittent Hypoxia Combined With Gait Training in Multiple Sclerosis
Behavioral and Electrophysiological Evidence of the Modulation of Fatigue in RR-MS
A Study of Remibrutinib Using MR Imaging in Relapsing or Progressive MS
Healthy Eating and Active Living for People Living With Multiple Sclerosis (HEAL MS): A Lifestyle Program for People With Multiple Sclerosis
Combined Motor Imagery and Vestibular Rehab for MS
Multicenter Prospective Study Analyzing the Occurrence of Multiple Sclerosis Relapses Without Radiological Evidence: Myth or Reality?
Educational Programs Based on Healthy Habits to Improve Quality of Life and Psychosocial Profile in Women With Neurodegenerative Diseases: the ADVICE Protocol Study (Phase 2)
Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis
Wearable Focal Vibration Therapy on Upper Extremity Function of People With Multiple Sclerosis: A Pilot Study
Effects of Ublituximab on Motor Functions in Multiple Sclerosis
Myrosinase Bioactivated Gglucoraphanin for the Treatment of Neurodegenerative Diseases (GRA-MYR-ND)
Home Based Functional Balance Intervention for Multiple Sclerosis